IL1B and neoplasm: The proteinase 3 inhibitor sivelestat diminishes the tumor-secreted protease cathepsin C-induced activation of PR3-IL-1β-NF-κB-mediated recruitment of neutrophils and NETosis, thus further inhibiting NET-dependent colonization of tumor cells [66].